The use of oligonucleotide aptamers in cancer therapy

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue

Abstract

Aptamers are a new class of molecules which originated in the 1990s. They are usually RNA or DNA oligonucleotides, the length of which ranges between 20 and 80 nt. They are produced using the SELEX method that allows one to obtain aptamers that bind to virtually any molecule of interest, providing a high specificity. Aptamers are an alternative to antibodies because on the one hand, their sensitivity is at a similar or sometimes even higher level, while on the other hand they do not show immunogenicity, and may be synthesized in vitro. To date, a broad range of different applications of aptamers has been described: as components of biosensors, or use in various laboratory techniques, such as microarrays or chromatography. One of the most important is the use of aptamers in medicine, especially in the fight against cancer. They can be used both for diagnosis and for the eradication of cancers – particularly through the delivery of drugs. Currently, most transport-related research is devoted to the delivery of chemotherapeutic drugs, such as doxorubicin. This was used in research on liver cancer cells, prostate, and acute lymphoblastic leukemia blast cells. Another possibility is to use aptamers to deliver siRNAs. In this way inhibition of the quality control process of the mRNA in tumor cells is possible. An aptamer complex with the drug allows for direct delivery of the active substance in a particular cell type, substantially eliminating the non-specific effect of the drug.

Authors and Affiliations

Adrian Odrzywolski, Adam Waśko

Keywords

Related Articles

Struktura chromosomu bakteryjnego – metody analizy oddziaływań białko-DNA in vivo

Badania prowadzone w ostatnich latach ujawniły, że chromosom bakteryjny wykazuje hierarchiczną organizację. Liczne białka wiążące DNA kondensują chromosom lokalnie oraz zapewniają jego odpowiednie upakowanie w skali glob...

Subkliniczne zmiany miażdżycowe tętnic szyjnych i czynniki ryzyka sercowo-naczyniowego u pacjentów zakażonych HIV

Wstęp: U osób zakażonych HIV, zwłaszca leczonych antyretrowirusowo, obserwuje się zwiększone ryzyko i występowanie chorób sercowo-naczyniowych. Cele pracy: Celem pracy jest ocena zaawansowania subklinicznych zmian miażdż...

Matczyna otyłość a rozwój mięśni szkieletowych u potomstwa – płodowe pochodzenie zaburzeń metabolicznych

Brak optymalnych warunków do życia dla rozwijającego się płodu, z powodu niewłaściwego odżywiania matki, otyłości, zapalenia lub cukrzycy naraża płód na sygnały humoralne, które modyfikują metabolizm, parametry wzrostu i...

The roles of orphan nuclear receptors in T-lymphocyte development in the thymus

T-lymphocyte development in the thymus proceeds through successive steps of differentiation, selection and expansion of thymocytes. Multiple signaling proteins and transcription factors play important roles in mediating...

Primary Immunodeficiency with double strain break DNA (DSBs) and radiosensitvity: clinical, diagnostic and therapeutic implications

Primary Immunodeficiencies (PNO) are a group of about 300 genetic disorders which result from the absence or dysfunction of the major components of the immune system. Among them an important subgroup constitute deficienc...

Download PDF file
  • EP ID EP220661
  • DOI -
  • Views 156
  • Downloads 0

How To Cite

Adrian Odrzywolski, Adam Waśko (2016). The use of oligonucleotide aptamers in cancer therapy. Advances in Hygiene and Experimental Medicine, 70(), 400-409. https://www.europub.co.uk/articles/-A-220661